Sun, Y.; Li, F.; Sonnemann, H.; Jackson, K.R.; Talukder, A.H.; Katailiha, A.S.; Lizee, G.
Evolution of CD8+ T Cell Receptor (TCR) Engineered Therapies for the Treatment of Cancer. Cells 2021, 10, 2379.
https://doi.org/10.3390/cells10092379
AMA Style
Sun Y, Li F, Sonnemann H, Jackson KR, Talukder AH, Katailiha AS, Lizee G.
Evolution of CD8+ T Cell Receptor (TCR) Engineered Therapies for the Treatment of Cancer. Cells. 2021; 10(9):2379.
https://doi.org/10.3390/cells10092379
Chicago/Turabian Style
Sun, Yimo, Fenge Li, Heather Sonnemann, Kyle R. Jackson, Amjad H. Talukder, Arjun S. Katailiha, and Gregory Lizee.
2021. "Evolution of CD8+ T Cell Receptor (TCR) Engineered Therapies for the Treatment of Cancer" Cells 10, no. 9: 2379.
https://doi.org/10.3390/cells10092379
APA Style
Sun, Y., Li, F., Sonnemann, H., Jackson, K. R., Talukder, A. H., Katailiha, A. S., & Lizee, G.
(2021). Evolution of CD8+ T Cell Receptor (TCR) Engineered Therapies for the Treatment of Cancer. Cells, 10(9), 2379.
https://doi.org/10.3390/cells10092379